Dedicated to supporting the development of, and access to, effective treatments for rare diseases and uncommon cancers. Comradis provides communications and commercialization expertise to organizations looking to improve standards of care for those affected by rare diseases and uncommon cancers. Our goal is to ensure that novel therapies reach those that need them as quickly and cost-efficiently as possible. We deliver services to pharmaceutical companies, rare disease specialists and patient advocacy organizations from our offices in New Zealand, China, Singapore, UAE, Switzerland, UK and USA. Comradis is part of AMICULUM, an independent global healthcare communications and learning business established in 2001. For further information on the support available from Comradis, please contact Jonathan Morton: jonathan.morton@comradis.biz